FDA
approval
· 2022-06-17
FDA Approved: SUMATRIPTAN — Supplemental Application (Aurobindo Pharma Limited)
Summary
FDA approved a supplemental application for Sumatriptan succinate from Aurobindo Pharma Limited, resulting in updated labeling for the product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SUMATRIPTAN (SUMATRIPTAN SUCCINATE)